Brokerages forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce earnings of $0.60 per share for the current quarter, according to Zacks. Two analysts have issued estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $0.57 to $0.62. U.S. Physical Therapy posted earnings per share of $0.57 in the same quarter last year, which would suggest a positive year over year growth rate of 5.3%. The company is expected to announce its next quarterly earnings report on Thursday, August 3rd.
On average, analysts expect that U.S. Physical Therapy will report full year earnings of $2.13 per share for the current fiscal year, with EPS estimates ranging from $2.12 to $2.15. For the next year, analysts expect that the firm will report earnings of $2.35 per share. Zacks’ EPS calculations are a mean average based on a survey of analysts that that provide coverage for U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, June 29th. The company reported $0.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.49 by $0.02. The firm had revenue of $97.57 million for the quarter, compared to the consensus estimate of $97.60 million. U.S. Physical Therapy had a return on equity of 12.44% and a net margin of 6.44%.
A number of brokerages have issued reports on USPH. Jefferies Group LLC reissued a “hold” rating and set a $63.00 target price on shares of U.S. Physical Therapy in a report on Friday, June 30th. BidaskClub cut shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a report on Sunday, July 16th. Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a report on Thursday, June 8th. Finally, Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target on the stock in a report on Monday, July 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. U.S. Physical Therapy has an average rating of “Hold” and a consensus target price of $66.67.
WARNING: This story was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://stocknewstimes.com/2017/07/21/analysts-anticipate-u-s-physical-therapy-inc-usph-to-post-0-60-earnings-per-share.html.
Shares of U.S. Physical Therapy (NYSE USPH) opened at 61.90 on Friday. The firm has a 50 day moving average price of $62.88 and a 200-day moving average price of $66.89. The firm has a market cap of $778.58 million, a P/E ratio of 37.29 and a beta of 1.06. U.S. Physical Therapy has a one year low of $51.96 and a one year high of $78.00.
The company also recently declared a quarterly dividend, which was paid on Friday, July 7th. Stockholders of record on Friday, June 16th were issued a $0.20 dividend. The ex-dividend date was Wednesday, June 14th. This represents a $0.80 annualized dividend and a dividend yield of 1.29%. U.S. Physical Therapy’s payout ratio is currently 42.33%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in U.S. Physical Therapy by 166,319.0% in the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock valued at $101,501,000 after buying an additional 1,553,419 shares during the last quarter. Vanguard Group Inc. boosted its position in U.S. Physical Therapy by 6.5% in the first quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock valued at $41,892,000 after buying an additional 39,290 shares during the last quarter. Aberdeen Asset Management PLC UK boosted its position in U.S. Physical Therapy by 11.0% in the first quarter. Aberdeen Asset Management PLC UK now owns 621,754 shares of the company’s stock valued at $40,601,000 after buying an additional 61,715 shares during the last quarter. Renaissance Technologies LLC boosted its position in U.S. Physical Therapy by 2.2% in the first quarter. Renaissance Technologies LLC now owns 605,000 shares of the company’s stock valued at $39,506,000 after buying an additional 13,300 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in U.S. Physical Therapy by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 482,922 shares of the company’s stock valued at $31,535,000 after buying an additional 4,361 shares during the last quarter. 96.89% of the stock is currently owned by hedge funds and other institutional investors.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
